Literature DB >> 18005204

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Alberto Briganti1, Andrea Gallina, Nazareno Suardi, Felix K-H Chun, Jochen Walz, Roman Heuer, Andrea Salonia, Alexander Haese, Paul Perrotte, Luc Valiquette, Markus Graefen, Patrizio Rigatti, Francesco Montorsi, Hartwig Huland, Pierre I Karakiewicz.   

Abstract

OBJECTIVE: To compare the performance and discriminant properties of two instruments (a tree-structured regression model and a logistic regression-based nomogram), recently developed to predict lymph node invasion (LNI) at radical prostatectomy (RP), in a contemporary cohort of European patients. PATIENTS AND METHODS: The cohort comprised 1525 consecutive men treated with RP and bilateral pelvic LN dissection (PLND) in two tertiary academic centres in Europe. Clinical stage, pretreatment prostate-specific antigen (PSA) level and biopsy Gleason sum were used to test the ability of the regression tree and the nomogram to predict LNI. Accuracy was quantified by the area under the receiver operating characteristic curve (AUC). All analyses were repeated for each participating institution.
RESULTS: The AUC for the nomogram was 81%, vs 77% for the regression tree (P = 0.007). When data were stratified according to institution, the nomogram invariably had a higher AUC than the regression tree (Hamburg cohort: nomogram 82.1% vs regression tree 77.0%, P = 0.002; Milan cohort: 82.4% vs 75.9%, respectively; P = 0.03).
CONCLUSIONS: Nomogram-based predictions of LNI were more accurate than those derived from a regression tree; therefore, we recommend the use of nomogram-derived predictions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005204     DOI: 10.1111/j.1464-410X.2007.07321.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

1.  Should all men having a radical prostatectomy have a pelvic lymph node dissection? No.

Authors:  Firas Abdollah; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

Review 2.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.

Authors:  Giovanni Lughezzani; Alberto Briganti; Pierre I Karakiewicz; Michael W Kattan; Francesco Montorsi; Shahrokh F Shariat; Andrew J Vickers
Journal:  Eur Urol       Date:  2010-08-06       Impact factor: 20.096

3.  Current status of pelvic lymph node dissection in prostate cancer.

Authors:  Ilija Aleksic; Tyler Luthringer; Vladimir Mouraviev; David M Albala
Journal:  J Robot Surg       Date:  2013-12-11

Review 4.  Formalized prediction of clinically significant prostate cancer: is it possible?

Authors:  Carvell T Nguyen; Michael W Kattan
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

5.  A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care.

Authors:  N R Abu-Rustum; Q Zhou; J D Gomez; K M Alektiar; M L Hensley; R A Soslow; D A Levine; D S Chi; R R Barakat; A Iasonos
Journal:  Gynecol Oncol       Date:  2010-03       Impact factor: 5.482

6.  Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT.

Authors:  Youngho Seo; Carina Mari Aparici; Chien Peter Chen; Charles Hsu; Norbert Kased; Carole Schreck; Nick Costouros; Randall Hawkins; Katsuto Shinohara; Mack Roach Iii
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

7.  Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.

Authors:  D M Fanning; F Yue; J M Fitzpatrick; R W G Watson
Journal:  Ir J Med Sci       Date:  2009-07-14       Impact factor: 1.568

8.  MRI and 11C Acetate PET/CT for Prediction of Regional Lymph Node Metastasis in Newly Diagnosed Prostate Cancer.

Authors:  Catrin von Below; Cecilia Wassberg; Rafael Grzegorek; Joel Kullberg; Charlotta Gestblom; Jens Sörensen; Mauritz Waldén; Håkan Ahlström
Journal:  Radiol Oncol       Date:  2018-01-24       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.